Trial Profile
Tociluzimab effect on Endothelial function in patients with Rheumatoid Arthritis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TEFRA
- 08 Apr 2019 Status changed to discontinued.
- 08 Mar 2016 New trial record